Results 31 to 40 of about 60,520 (273)

OLANZAPINE AND HYPERTRIGLYCERIDEMIA

Journal of the American Academy of Child & Adolescent Psychiatry, 2001
Journal of the American Academy of Child & Adolescent Psychiatry 40 (2001) 133-133.
Division of Child and Adolescent Psychiatry, University of Florida, Gainesville ( host institution ), Nguyen, Mathew, Murphy, Tanya   +2 more
openaire   +3 more sources

Olanzapine versus Placebo in Outpatient Adults with Anorexia Nervosa: A randomized clinical trial

American Journal of Psychiatry, 2019
Objective. This study evaluated the benefits of olanzapine versus placebo for adult outpatients with anorexia nervosa. Method: This randomized, double-blind, placebo-controlled trial of adult outpatients with anorexia nervosa was conducted at five sites ...
Evelyn Attia, J. Steinglass, B. Walsh, Yuan-Jia Wang, Peng Wu, Colleen C. Schreyer, J. Wildes, Zeynep Yilmaz, A. Guarda, A. Kaplan, M. Marcus   +10 more
semanticscholar   +1 more source

Olanzapine pamoate use for schizophrenia: Retrospective records based study from a tertiary care hospital

Indian Journal of Psychological Medicine, 2020
Background: Little is known from India about the experience of using olanzapine long-acting antipsychotic injectables (LAI). In this background, this study aimed to evaluate the clinical profile of patients suffering from schizophrenia who were ...
Sandeep Grover, Himanshu Singla, Subho Chakrabarti, Ajit Avasthi   +3 more
doaj   +1 more source

Deep Brain Stimulation Reduces Conflict‐Related Theta and Error‐Related Negativity in Patients With Obsessive–Compulsive Disorder

Neuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives Obsessive–compulsive disorder (OCD) is a psychiatric disorder with alterations of cortico‐striato‐thalamo‐cortical loops and impaired performance monitoring. Electrophysiological markers such as conflict‐related medial frontal theta (MFT) and error‐related negativity (ERN) may be altered by clinically effective deep brain ...
Elena Sildatke, Theo O. J. Gruendler, Markus Ullsperger, Till A. Dembek, Juan Carlos Baldermann, Sina Kohl, Veerle Visser‐Vandewalle, Daniel Huys, Jens Kuhn, Thomas Schüller   +9 more
wiley   +1 more source

Metformin and berberine prevent olanzapine-induced weight gain in rats. [PDF]

PLoS ONE, 2014
Olanzapine is a first line medication for the treatment of schizophrenia, but it is also one of the atypical antipsychotics carrying the highest risk of weight gain.
Yueshan Hu, Alan J Young, Erik A Ehli, Dustin Nowotny, Paige S Davies, Elizabeth A Droke, Timothy J Soundy, Gareth E Davies   +7 more
doaj   +1 more source

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.

Lancet psychiatry, 2018
BACKGROUND No established treatment algorithm exists for patients with schizophrenia. Whether switching antipsychotics or early use of clozapine improves outcome in (first-episode) schizophrenia is unknown. METHODS This three-phase study was done in 27
R. Kahn, Inge Winter-van Rossum, S. Leucht, P. McGuire, S. Lewis, M. Leboyer, C. Arango, P. Dazzan, R. Drake, S. Heres, C. Díaz-Caneja, D. Rujescu, M. Weiser, S. Galderisi, B. Glenthøj, M. Eijkemans, W. Fleischhacker, Shitij Kapur, I. Sommer, Inge Winter-van Rossum, M. Somers, Paula C. Ywema, Shitisj Kapur, A. Meyer-Lindenberg, W. Fleischhacker, Anne Lotte Meijering, Jocelyn Petter, Resy Van de Brug, Joost Schotsman, Jildou Zwerver, J. Peuskens, M. de Hert, E. Thys, L. Hranov, Valentin Hranov, Jan Libiger, Richard Köhler, Pavel Mohr, B. Glenthøj, Brian Broberg, S. Düring, L. Baandrup, S. Jamain, I. Giegling, Mor Bar Heim, Michael Davidson, Paola Bucci, A. Mucci, J. Rybakowski, Agnieszka Remlinger-Molenda, Ilan Gonen, Paull Radu, Marina Díaz-Marsá, Alberto Rodriguez, T. Palomo, R. Rodríguez-Jiménez, P. García-Portilla, Miquel Bernardo, J. Bobes, Christina Vilares Oliveira, G. Berger, Claudia Wildt, Roccio Perez-Iglesias, Sarah Gregory, D. Wilson   +64 more
semanticscholar   +1 more source

Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis – results to be interpreted with caution [PDF]

, 2010
Randomized, controlled trials have demonstrated efficacy for second-generation antipsychotics in the treatment of acute mania in bipolar disorder. Despite depression being considered the hallmark of bipolar disorder, there are no published systematic ...
Goikolea, José Manuel, Krishnadas, R., Vieta i Pascual, Eduard, 1963-, Valentí Ribas, Marc, Sánchez-Moreno, José, Torres, Ferran, Livingston, M., Cruz, Nuria   +7 more
core   +1 more source

Entry of the antipsychotic drug, olanzapine, into the developing rat brain in mono- and combination therapies [version 1; peer review: 2 approved]

F1000Research, 2022
Background: Olanzapine is used to treat schizophrenia and bipolar disorder in women of childbearing age. Continuation of psychotropic medications throughout pregnancy and lactation is often required as cessation could be dangerous for both mother and ...
Mark Habgood, Katarzyna Dziegielewska, Yifan Huang, Shuai Nie, Fiona Qiu, Norman Saunders   +5 more
doaj   +1 more source

Olanzapine for the Prevention and Treatment of ICU Delirium: Protocol for a Systematic Review With Meta‐Analysis [PDF]

Acta Anaesthesiol Scand
ABSTRACT Background Intensive care unit (ICU) delirium is a multifactorial acute brain dysfunction associated with prolonged hospitalization, increased morbidity and mortality, and higher healthcare costs. Despite these substantial negative impacts of delirium, the optimal prevention and treatment strategies are unclear.
Liebetrau B, Madsen A, Möller S, Olsen M, Wiberg S, Mølstrøm S.   +5 more
europepmc   +2 more sources

Zebrafish shares common metabolic pathways with mammalian olanzapine-induced obesity

Future Journal of Pharmaceutical Sciences, 2020
Background Olanzapine is one of the most prescribed antipsychotic agents in the pharmacotherapy of psychiatric illness; however, it is associated with multiple side effects primarily obesity. Multiple investigations have been made to model the olanzapine-
Pukar Khanal, B. M. Patil, Banappa. S. Unger   +2 more
doaj   +1 more source